Arteris CEO’s Steady 10(b)(5) Sales: Insider Outflow Grows to 27,700 Shares on July 1, 2026—Market Holds Steady Amid Heightened Buzz

Insider Selling Spree at Arteris: What It Means for Investors

Arteris Inc. has just added another sizable sell‑off to its already active insider trading calendar, with President and CEO Janac K Charles selling roughly 27 700 shares on July 1, 2026. The transaction was executed under a 10(b)(5)(1) plan that Bayview Legacy, LLC—Charles’ investment vehicle—had adopted in December of last year. The sale was priced at an average of $45.04 per share, just above the current market price of $35.06, indicating a modest profit on the transaction.

A Pattern of Planned Distributions The July sale is part of a broader pattern of structured, plan‑based liquidations that Charles has conducted over the past six months. In late June, he sold 42 449 shares at $34.74 and 27 551 shares at $35.16, and in early May he off‑loaded 70 000 shares at a price of $31.20. Earlier in the year, the CEO sold 70 000 shares on December 8 at $17.71. These transactions have steadily reduced his post‑trade ownership from roughly 9.5 million shares in early June to just under 8.8 million after the July sale. The consistent use of 10(b)(5) plans suggests that the sales are pre‑planned and not driven by a sudden change in confidence in the company.

Market Reaction and Sentiment Despite the outflows, the market has largely shrugged off the news. The stock slipped only 0.20 % on the day of the sale, and social‑media sentiment remains mildly positive (+6 on a scale of –100 to +100). The buzz, however, was high at 107 %—above the normal communication intensity—indicating that investors are paying close attention to insider activity. This heightened chatter is a double‑edged sword: it can amplify price swings when the next insider sale is announced but also provides a valuable barometer of institutional interest.

What Investors Should Take Away

1. Signal of Confidence? The CEO’s use of 10(b)(5) plans suggests a long‑term view; the sales are scheduled, not reactionary. For shareholders, this may signal that the executive believes the shares are fairly valued at the time of sale.
2. Liquidity for the Company? Large insider sales can create a perception of liquidity but also risk a “run” on the stock if future sales are announced. The current price has been hovering near a six‑month low of $43.81, well below its 52‑week high of $50.26, indicating room for upside.
3. Competitive Landscape – Arteris operates in a high‑tech niche (network‑on‑chip IP) where margins and valuation multiples can be volatile. The CEO’s ongoing sales could be a hedge against potential downturns in the broader semiconductor cycle.

Janac K Charles: A Profile of the Selling CEO Charles has maintained a steady sell‑off cadence since early 2025, trading between 60 000 and 70 000 shares in most transactions. His total holdings have dropped from ~9.5 million to ~8.8 million in the past month, a 9 % reduction. Despite the volume, the average price per share has remained close to the market level, indicating he is not trying to “dump” the stock at depressed prices. Historically, Charles’ trades have been spread across multiple dates, minimizing market impact. The consistency of the 10(b)(5) plans, combined with the lack of any negative news on the company’s fundamentals, paints a picture of a CEO who is comfortable with the current valuation and is using scheduled sales to manage personal liquidity without signalling distress.

Bottom Line Arteris’ insider activity, driven largely by the CEO’s disciplined 10(b)(5) sales, is a reminder that large institutional shareholders can and do use pre‑planned selling to adjust personal portfolios. For investors, the key takeaway is that these sales are not necessarily a warning of impending decline; instead, they reflect a calculated approach to wealth management. The stock’s recent performance, coupled with a mild positive sentiment and a high communication buzz, suggests that the market is aware of insider movements but remains focused on the company’s core IP business and its potential to capture value as the semiconductor ecosystem evolves.